| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |